For: | Zhao L, Mou DC, Leng XS, Peng JR, Wang WX, Huang L, Li S, Zhu JY. Expression of cancer-testis antigens in hepatocellular carcinoma. World J Gastroenterol 2004; 10(14): 2034-2038 [PMID: 15237429 DOI: 10.3748/wjg.v10.i14.2034] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v10/i14/2034.htm |
Number | Citing Articles |
1 |
QIPING HU, JUN FU, BIN LUO, MIAO HUANG, WENWEN GUO, YONGDA LIN, XIAOXUN XIE, SHAOWEN XIAO. OY-TES-1 may regulate the malignant behavior of liver cancer via NANOG, CD9, CCND2 and CDCA3: A bioinformatic analysis combine with RNAi and oligonucleotide microarray. Oncology Reports 2015; 33(4): 1965 doi: 10.3892/or.2015.3792
|
2 |
Olga Gordeeva. Cancer-testis antigens: Unique cancer stem cell biomarkers and targets for cancer therapy. Seminars in Cancer Biology 2018; 53: 75 doi: 10.1016/j.semcancer.2018.08.006
|
3 |
Mahnaz Seifi-Alan, Roshanak Shamsi, Soudeh Ghafouri-Fard. Application of Cancer-Testis Antigens in Immunotherapy of Hepatocellular Carcinoma. Immunotherapy 2018; 10(5): 411 doi: 10.2217/imt-2017-0154
|
4 |
Weiming Yang, Weiheng Zhang, Xiaozhong Wang, Liming Tan, Hua Li, Jiemin Wu, Qiong Wu, Wanlei Sun, Juanjuan Chen, Yanhui Yin. HCA587 Protein Vaccine Induces Specific Antitumor Immunity Mediated by CD4+ T-cells Expressing Granzyme B in a Mouse Model of Melanoma. Anti-Cancer Agents in Medicinal Chemistry 2021; 21(6): 738 doi: 10.2174/1871520620666200728131951
|
5 |
|
6 |
Shin Eun, Kyoung Bun Lee, Soo Young Park, Woong Jae Yun, Tae Hoon Kang, Bo Sung Kim, Ja‐June Jang. Glypican‐3 and MAGE‐1 are predictors of tumor invasiveness of hepatocellular carcinoma. Basic and Applied Pathology 2008; 1(4): 174 doi: 10.1111/j.1755-9294.2008.01033.x
|
7 |
Jutta Ries, Eleftherios Vairaktaris, Nur Mollaoglu, Joerg Wiltfang, Friedrich W. Neukam, Emeka Nkenke. Expression of melanoma‐associated antigens in oral squamous cell carcinoma. Journal of Oral Pathology & Medicine 2008; 37(2): 88 doi: 10.1111/j.1600-0714.2007.00600.x
|
8 |
Qing Deng, Kun-Yu Li, Hui Chen, Ji-Hong Dai, Yang-Yang Zhai, Qun Wang, Niu Li, Yu-Ping Wang, Ze-Guang Han. RNA interference against cancer/testis genes identifies dual specificity phosphatase 21 as a potential therapeutic target in human hepatocellular carcinoma. Hepatology 2014; 59(2): 518 doi: 10.1002/hep.26665
|
9 |
Chunmei Fan, Hongke Qu, Xu Wang, Navid Sobhani, Leiming Wang, Shuanglin Liu, Wei Xiong, Zhaoyang Zeng, Yong Li. Cancer/testis antigens: from serology to mRNA cancer vaccine. Seminars in Cancer Biology 2021; 76: 218 doi: 10.1016/j.semcancer.2021.04.016
|
10 |
Laura Senovilla, Erika Vacchelli, Pauline Garcia, Alexander Eggermont, Wolf Hervé Fridman, Jérôme Galon, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi. Trial watch. OncoImmunology 2013; 2(4): e23803 doi: 10.4161/onci.23803
|
11 |
Michael A. Morse, Timothy M. Clay, H Kim Lyerly. General Principles of Tumor Immunotherapy. 2007; : 17 doi: 10.1007/978-1-4020-6087-8_2
|
12 |
Norma Bloy, Aitziber Buqué, Fernando Aranda, Francesca Castoldi, Alexander Eggermont, Isabelle Cremer, Catherine Sautès-Fridman, Jitka Fucikova, Jérôme Galon, Radek Spisek, Eric Tartour, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi. Trial watch: Naked and vectored DNA-based anticancer vaccines. OncoImmunology 2015; 4(5): e1026531 doi: 10.1080/2162402X.2015.1026531
|
13 |
Marc‐Oliver Riener, Peter J. Wild, Christopher Soll, Alexander Knuth, Boquan Jin, Achim Jungbluth, Claus Hellerbrand, Pierre‐Alain Clavien, Holger Moch, Wolfram Jochum. Frequent expression of the novel cancer testis antigen MAGE‐C2/CT‐10 in hepatocellular carcinoma. International Journal of Cancer 2009; 124(2): 352 doi: 10.1002/ijc.23966
|
14 |
Elisabetta Fratta, Sandra Coral, Alessia Covre, Giulia Parisi, Francesca Colizzi, Riccardo Danielli, Hugues Jean Marie Nicolay, Luca Sigalotti, Michele Maio. The biology of cancer testis antigens: Putative function, regulation and therapeutic potential. Molecular Oncology 2011; 5(2): 164 doi: 10.1016/j.molonc.2011.02.001
|
15 |
Tim F. Greten, Michael P. Manns, Firouzeh Korangy. Immunotherapy of hepatocellular carcinoma. Journal of Hepatology 2006; 45(6): 868 doi: 10.1016/j.jhep.2006.09.004
|
16 |
Salwa H. Teama, Sara H.A. Agwa, Noha A. ElNakeeb, Manal Abdel Hamid, Amany M. Maher, Mourad M. Heidar. Multiple molecular markers MAGE-1, MAGE-3 and AFP mRNAs expression nested PCR assay for sensitive and specific detection of circulating hepatoma cells: Enhanced detection of hepatocellular carcinoma. Egyptian Journal of Medical Human Genetics 2013; 14(1): 21 doi: 10.1016/j.ejmhg.2012.08.006
|
17 |
Natalay Kouprina, Vladimir N. Noskov, Greg Solomon, John Otstot, William Isaacs, Jianfeng Xu, Johanna Schleutker, Vladimir Larionov. Mutational analysis ofSPANXgenes in families with X‐Linked prostate cancer. The Prostate 2007; 67(8): 820 doi: 10.1002/pros.20561
|
18 |
V D'Arcy, N Pore, F Docquier, Z K Abdullaev, I Chernukhin, G-X Kita, S Rai, M Smart, D Farrar, S Pack, V Lobanenkov, E Klenova. BORIS, a paralogue of the transcription factor, CTCF, is aberrantly expressed in breast tumours. British Journal of Cancer 2008; 98(3): 571 doi: 10.1038/sj.bjc.6604181
|
19 |
Maurizio Chiriva-Internati, Fabio Grizzi, Cynthia A Jumper, Everardo Cobos, Paul L Hermonat, Eldo E Frezza. Immunological treatment of liver tumors. World Journal of Gastroenterology 2005; 11(42): 6571-6576 doi: 10.3748/wjg.v11.i42.6571
|
20 |
K. Kashofer, M.M. Tschernatsch, H.J. Mischinger, F. Iberer, K. Zatloukal. The disease relevance of human hepatocellular xenograft models: Molecular characterization and review of the literature. Cancer Letters 2009; 286(1): 121 doi: 10.1016/j.canlet.2008.11.011
|
21 |
Natalay Kouprina, Vladimir N. Noskov, Adam Pavlicek, N. Keith Collins, Pamela D. Schoppee Bortz, Chris Ottolenghi, Dmitri Loukinov, Paul Goldsmith, John I. Risinger, Jung-Hyun Kim, V. Anne Westbrook, Gregory Solomon, Hanna Sounders, John C. Herr, Jerzy Jurka, Victor Lobanenkov, David Schlessinger, Vladimir Larionov, Pawel Michalak. Evolutionary Diversification of SPANX-N Sperm Protein Gene Structure and Expression. PLoS ONE 2007; 2(4): e359 doi: 10.1371/journal.pone.0000359
|
22 |
M. Moehler, J. Heo, H.C. Lee, W.Y. Tak, Y. Chao, S.W. Paik, H.J. Yim, K.S. Byun, A. Baron, G. Ungerechts, D. Jonker, L. Ruo, M. Cho, A. Kaubisch, H. Wege, P. Merle, O. Ebert, F. Habersetzer, J.F. Blanc, Olivier Rosmorduc, R. Lencioni, R. Patt, A.M. Leen, F. Foerster, M. Homerin, N. Stojkowitz, M. Lusky, J.M. Limacher, M. Hennequi, N. Gaspar, B. McFadden, N. De Silva, D. Shen, A. Pelusio, D.H. Kirn, C.J. Breitbach, J.M. Burke. Vaccinia-based oncolytic immunotherapy Pexastimogene Devacirepvec in patients with advanced hepatocellular carcinoma after sorafenib failure: a randomized multicenter Phase IIb trial (TRAVERSE). OncoImmunology 2019; 8(8) doi: 10.1080/2162402X.2019.1615817
|
23 |
Fabio Grizzi, Barbara Franceschini, Cody Hamrick, Eldo E Frezza, Everardo Cobos, Maurizio Chiriva-Internati. Usefulness of cancer-testis antigens as biomarkers for the diagnosis and treatment of hepatocellular carcinoma. Journal of Translational Medicine 2007; 5(1) doi: 10.1186/1479-5876-5-3
|
24 |
JUN-DONG ZHOU, FEI SHEN, JIAN-SONG JI, KAI ZHENG, MIN HUANG, JIN-CHANG WU. FAM9C plays an anti-apoptotic role through activation of the PI3K/Akt pathway in human hepatocellular carcinoma. Oncology Reports 2013; 30(3): 1275 doi: 10.3892/or.2013.2592
|